Status:
COMPLETED
Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Urological Surgical Operations
Lead Sponsor:
Saint Savvas Anticancer Hospital
Collaborating Sponsors:
University of Thessaly
Conditions:
Pregabalin on Catheter Related Bladder Discomfort
Eligibility:
All Genders
45-85 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this study is to assess the effect of pregabalin administration on catheter-related bladder discomfort (CRBD). The study group includes patients that are about to be subjected to urological...
Eligibility Criteria
Inclusion
- All patients about to be subjected to urinary operations
- Signed informed consent
Exclusion
- Preoperative urinary bladder/kidney dysfunction as a result of spinal cord pathology
- History of overactive ((urinary frequency\>3 times at night and \>8 times in 24 hours), neurogenic bladder
- End stage renal failure
- Central nervous system dysfunction
- Mental illness/ substance abuse
- Sensitivity to pregabalin
- Preoperative administration of pregabalin for other indications
- Recent bladder catheterization \<3 months
Key Trial Info
Start Date :
July 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2020
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT03229668
Start Date
July 28 2017
End Date
February 20 2020
Last Update
March 31 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Anticancer Hospital of Athens "Saint Savvas"
Athens, Greece, 115 22
2
University of Thessaly, Medical School
Volos, Greece, 38221